113 related articles for article (PubMed ID: 7590083)
1. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S
Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083
[TBL] [Abstract][Full Text] [Related]
2. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats.
Yokoyama T; Masuda Y; Sakai T; Tanaka S; Tomita K
J Cardiovasc Pharmacol; 1992 Jun; 19(6):851-6. PubMed ID: 1376803
[TBL] [Abstract][Full Text] [Related]
3. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K
Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
Kawabata M; Ogawa T; Han WH; Takabatake T
Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
[TBL] [Abstract][Full Text] [Related]
5. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
[TBL] [Abstract][Full Text] [Related]
7. Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats.
Shudo C; Masuda Y; Sugita H; Tanaka S; Tomita K
Gen Pharmacol; 1994 Nov; 25(7):1451-8. PubMed ID: 7896060
[TBL] [Abstract][Full Text] [Related]
8. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats.
Ichihara K; Okumura K; Kamei H; Nagasaka M; Kanda A; Kanno T; Miyoshi K; Miyake H
J Cardiovasc Pharmacol; 1998 Feb; 31(2):277-85. PubMed ID: 9475270
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100
[TBL] [Abstract][Full Text] [Related]
11. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
12. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
[TBL] [Abstract][Full Text] [Related]
13. Influence of efonidipine hydrochloride, calcium antagonist on the epithelium of prostates in spontaneously hypertensive rats.
Furukawa S; Yamamoto O; Tamura T; Masuda Y; Shudo C; Hayashi K; Hirata H
J Toxicol Sci; 1994 Nov; 19(4):213-7. PubMed ID: 7884832
[TBL] [Abstract][Full Text] [Related]
14. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
[TBL] [Abstract][Full Text] [Related]
15. Effects of CV-4093, a new dihydropyridine calcium channel blocker, on renal hemodynamics and function in stroke-prone spontaneously hypertensive rats (SHRSP).
Morimoto S; Ohyama T; Hisaki K; Matsumura Y
Jpn J Pharmacol; 1989 Oct; 51(2):257-65. PubMed ID: 2593383
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic action of manidipine hydrochloride, a new calcium channel blocker, in spontaneously hypertensive rats.
Nagaoka A; Shibota M
Jpn J Pharmacol; 1989 Oct; 51(2):299-301. PubMed ID: 2593386
[TBL] [Abstract][Full Text] [Related]
17. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
Watanabe S; Ono H; Ishimitsu T; Matsuoka H; Ono Y; Fujimori T
Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
[TBL] [Abstract][Full Text] [Related]
18. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
Ikenaga H; Suzuki H; Saruta T
Blood Press Suppl; 1992; 3():75-9. PubMed ID: 1343295
[TBL] [Abstract][Full Text] [Related]
19. Effect of a calcium antagonist on renal hemodynamics in salt-loaded spontaneously hypertensive rats.
Shimosawa T; Ando K; Fujita T
Jpn Heart J; 1995 Nov; 36(6):797-805. PubMed ID: 8627985
[TBL] [Abstract][Full Text] [Related]
20. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
